Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 317,823	$ 555,320
Trade accounts receivable, less allowance for doubtful accounts (2019 – $4,391; 2018 – $4,460)	637,037	605,712
Other accounts receivable	86,556	52,059
Inventories	802,434	700,540
Other current assets	125,902	84,790
Total current assets	1,969,752	1,998,421
Property, plant and equipment, at cost	5,406,123	4,799,063
Less accumulated depreciation and amortization	1,882,086	1,777,979
Net property, plant and equipment	3,524,037	3,021,084
Investments	551,657	528,722
Other assets	200,858	80,135
Goodwill	1,534,241	1,567,169
Other intangibles, net of amortization	361,058	386,143
Total assets	8,141,603	7,581,674
Current liabilities:
Accounts payable	527,052	522,516
Accrued expenses	273,709	257,323
Current portion of long-term debt	539,960	307,294
Dividends payable	38,678	35,169
Current operating lease liability	24,606	0
Income taxes payable	17,238	60,871
Total current liabilities	1,421,243	1,183,173
Long-term debt	1,381,984	1,397,916
Postretirement benefits	45,752	46,157
Pension benefits	272,345	285,396
Other noncurrent liabilities	618,822	526,942
Deferred income taxes	393,120	382,982
Commitments and contingencies (Note 9)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, issued and outstanding – 106,031 in 2019 and 105,616 in 2018	1,060	1,056
Additional paid-in capital	1,379,419	1,368,897
Accumulated other comprehensive loss	(435,977)	(350,682)
Retained earnings	2,892,057	2,566,050
Total Albemarle Corporation shareholders’ equity	3,836,559	3,585,321
Noncontrolling interests	171,778	173,787
Total equity	4,008,337	3,759,108
Total liabilities and equity	$ 8,141,603	$ 7,581,674